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ABSTRACT. Chronic renal disorders have a progressive course in most cases, and finally result
in end-stage renal disease (ESRD). Hemodialysis (HD) is one of the mainstays in the treatment of
these patients. Disturbance in calcium (Ca) and phosphorus (P) metabolism and alteration of
serum levels of parathormone (PTH) are observed in these patients. One of the most common
cutaneous manifestations in patients on HD is pruritus. The aim of this study is to evaluate the
association between pruritus and serum concentrations of Ca, P and PTH in patients with chronic
renal disease. This analytic, descriptive, cross-sectional study was performed on 120 patients on
HD at the Fifth-Azar Hospital in Gorgan, Iran, in 2010. Information related to the patients, inclu-
ding age, gender, pruritus, time of pruritus and duration on dialysis, was extracted from question-
naires. Serum concentrations of intact PTH, Ca and P were measured. Data were analyzed by the
chi-square test and SPSS-16 software. A P-value less than 0.05 was considered statistically signi-
ficant. Among the 120 study patients, 50% were male and the mean age (±SD) was 49 ± 12.3
years. Sixty percent of the patients had pruritus, of whom 33.3% had PTH levels above the
normal range. Among the 40% of the patients who did not have pruritus, 39.6% had PTH levels
higher than the normal levels. The mean serum Ca and P levels were 8.44 ± 1.65 mg/dL and 5.48
± 1.81 mg/dL, respectively. The mean (±SD) Ca–P product was 55.46 ± 47.16 and the mean PTH
concentration was 274.34 ± 286.53 pg/mL. No significant association was found between pruritus
and age, sex, serum PTH and P levels as well as Ca–P product. However, the association between
serum Ca levels and pruritus was significant (P = 0.03). Our study showed that most patients with
pruritus had serum Ca levels in the abnormal range (lower or higher), and there was no significant
correlation between serum iPTH level and pruritis. Thus, good control of serum Ca levels is
important to reduce pruritus in these patients.
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Introduction
Chronic renal disease has a progressive
course in most cases, and finally results in
end-stage renal disease (ESRD). Various treat-
ments have been considered for these patients,
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and one of the main options is hemodialysis
(HD).1 Patients with renal failure who are on
treatment with HD suffer from mucosal and
cutaneous lesions, which often annoy patients.
These mucocutaneous manifestations may be
related to uremia, previous underlying disease,
drugs and/or HD treatment.2 The serum levels
of calcium (Ca), phosphorus (P) and parathor-
mone (PTH) are the most important bio-
chemical factors that get altered in these
patients. One of the most common compli-
cations seen in patients on HD is pruritus, the
prevalence of which in patients with chronic
renal failure (CRF) is between 37% and 90%;
this rate is about 80% in patients on HD.3 The
etiology of pruritus has not been completely
understood in these patients and its patho-
physiology depends on several factors. In
chronic kidney disease (CKD), there is ele-
vated PTH concentration secondary to derange-
ment of Ca, P and vitamin D metabolism.
Generally, hyperphosphatemia, hypocalcemia
and decreased calcitriol production can all in-
crease the PTH production and hyperplasia of
parathyroid cells, finally resulting in secondary
hyperparathyroidism.4 Hyperparathyroidism can
stimulate mast cells to release histamine and
increase deposition of Ca and magnesium salts
on the skin. However, not all patients with
severe hyperparathyroidism have pruritus. In
addition, in some of the studies, no association
has been found between plasma levels of PTH
and cutaneous proliferation and number of
mast cells.5 In view of the high prevalence of
pruritus in patients on dialysis and its un-
known etiology as well as the lack of a safe
treatment for pruritus, further investigations in
this field are necessary. The aim of this study
is to evaluate the association between pruritus
and serum levels of PTH, Ca and P in patients
on HD.
Materials and Methods
  This descriptive–analytic, cross-sectional study
was conducted on 120 patients who were on
HD at the Fifth-Azar Hospital in Gorgan in
2010. The diagnosis of ESRD was confirmed
by the nephrologists. Data were collected from
questionnaires, and included age, gender, pru-
ritus, time of developing pruritus and duration
on HD. iPTH was measured by the enzyme-
linked immunosorbent assay, Ca by CPC and a
spectrophotometer and P by the ultraviolet
technique. According to the Kidney Diseases
Outcome and Quality Initiative, the acceptable
level of serum Ca in patients with ESRD is
8.4–9.5 mg/dL, of P is 3.5–5.5 mg/dL and of
iPTH is 150–300 pg/mL. Age, as a qualitative
variable, was considered in three groups (15–
35, 35–55 and 55–75 years). Data were ana-
lyzed by the chi-square test and SPSS-16 soft-
ware. A P-value less than 0.05 was considered
as being statistically significant.
Results
Among the 120 HD patients studied, half
were males. The mean age ± standard devia-
tion was 49 ± 12.3 years, duration on dialysis
was 3.84 ± 4.05 years, serum Ca concen-
tration was 8.44 ± 1.65 m/dL, serum PTH level
was 274.34 ± 286.53 pg/mL, serum P level
was 5.48 ± 1.81 mg/dL and Ca–P product was
55.46 ± 47.16.
In this study, 60% of the patients had pru-
ritus; the PTH was higher than normal in
33.3% of them. In contrast, 39.6% of the pa-
tients without pruritus had high PTH concen-
trations. The association of pruritus and inde-
pendent variables has been shown in Table 1.
As shown, pruritus had no statistically signi-
ficant difference between the two genders (P =
1.00). The serum PTH concentration was
below normal in 55%, normal in 9.16% and
above the normal limit in 35.83% of the pa-
tients. No significant association was found
between age, gender, serum PTH, serum P le-
vels and the Ca–P product and pruritus, while
the association between serum Ca level and
pruritus was significant (P = 0.03). The serum
Ca was below normal in 54.2% of the patients
with pruritus and 44.7% of patients without
pruritus. The prevalence of pruritus, before or
after dialysis, had no relationship with serum
Ca and P levels (P > 0.05). The serum Ca and
P levels showed no significant association with
the serum PTH level (P >0.05). The association
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between Ca–P product and serum PTH in the
study patients according to gender and age
groups is summarized in Table 2. The only
significant association seen was in the serum
PTH levels in the various age groups (P
<0.01); the age group 15–35 years had higher
serum PTH levels while most of the other age
groups had lower PTH levels.
Discussion
In this study, pruritus was found in 60% of
the patients. In previous studies, the reported
prevalence of pruritus has been higher, while
in some other studies, it has been lower than
that in our study. For instance, pruritus was
observed in 58.8% of the patients by
Szepietowski,6 41.9% by Akhiani et al,7 70%
by Yazdanpanah et al8 and 72.8% by Omori
Kentaro et al from Japan.9 These differences
may be due to the prevailing climatic con-
ditions. Comparison of these results shows
that, generally, more than half of the patients
complained of pruritus in most studies.
  In the study by Narita et al, there was a sig-
nificant association between serum PTH levels
and pruritus.10 In the study by Yazdanpanah,
the serum PTH level was normal in 60% of the
patients and 84% complained of pruritus. They
found a significant difference in the serum
PTH levels in patients with and without
pruritus.8 In addition, Stable-backdahlm et al
also reported that the serum PTH level in HD
patients with pruritis was significantly higher
than in those without pruritus. However, no
association was found between the severity of
Table 1. Association between pruritus and independent variables in the study subjects.
With pruritus Without pruritusVariables Classification
No. (%) No. (%)
P-
value
Male 36 (50) 24 (50)
Gender
Female 36 (50) 24 (50)
NS
15–35 years 10 (13.9) 13 (27.1)
35–55 years 37 (51.4) 19 (39.6)Age groups
55–75 years 25 (34.7) 16 (33.3)
NS
Higher than normal 29 (40.3) 22 (45.8)
Normal 37 (51.4) 21 (43.8)Serum phosphorus level
Lower than normal 6 (8.3) 5 (10.4)
NS
Higher than normal 19 (26.4) 7 (14.9)
Normal 14 (19.4) 19 (40.4)Serum calcium level
Lower than normal 39 (54.2) 21 (44.7)
0.03
More than 55 18 (25) 13 (27.1)
Calcium–phosphorus product
Less than 55 54 (75) 35 (72.9)
NS
Higher than normal 24 (33.3) 19 (39.6)
Normal 6 (8.3) 5 (10)Serum parathormone level
Lower than normal 42 (58.3) 24 (50)
NS
Table 2. The association of calcium–phosphorus product and serum parathormone with gender and age
groups in the study subjects.
Calcium–phosphorus
product Serum parathormone level
Less than
55
More
than 55
Less than
normal Normal
More than
normal
Variable
No. (%) No. (%)
P
No. (%) No. (%) No. (%)
P
Male 47 (54) 12 (38.7) 30 (45.5) 7 (63.6) 23 (53.5)
Gender
Female 40 (46) 19 (61.3)
NS
36 (54.5) 4 (36.4) 20 (46.5)
NS
15–35 15 (17.2) 8 (25.8) 5 (7.6) 3 (27.3) 15 (34.9)
35–55 39 (44.8) 15 (48.4) 32 (48.5) 7 (63.6) 17 (39.5)Age groups(years)
55–75 33 (37.9) 8 (25.8)
NS
29 (43.9) 1 (9.1) 11 (25.6)
<0.01
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symptoms and the serum PTH levels.11 In the
present study, contrary to the three previous
studies, the serum PTH concentration in pa-
tients with and without pruritus showed no
significant difference (P = 0.66). This finding
is similar to the results of Kakuu et al,12
Akhiyani et al7 and Szepietowski et al,6 in
which no significant association was found
between pruritus and serum PTH levels.
Narita et al and Omori Kentaro et al, in their
studies, showed that male gender was an im-
portant factor for developing severe pru-
ritus;9,10 in our study, there was no statistically
significant association between pruritus and
male and female genders (P = 1.00). Omori
Kentaro et al reported a significant association
between pruritus and age; age younger than 30
years was associated with a lower risk for
pruritus,10 and no significant association was
found between age and pruritus in our study.
Narita et al and Szepietowski et al found that
the serum Ca concentration was significantly
higher in patients with pruritus when com-
pared with those without pruritus.6,10 In the
present study, majority of the cases with
pruritus had abnormal (increased or decreased)
serum Ca levels (Table 1). A reverse asso-
ciation was seen between pruritus and serum
Ca level in our study. Some other investigators
however found no significant association bet-
ween serum Ca and pruritus.7,11 Additionally,
many studies found no association between
serum P levels and pruritus.7,8,13 These findings
were similar to our study, although Omori
Kentaro et al reported a significant association
between hyperphosphatemia and pruritus.10
Many studies have reported a significant asso-
ciation between the Ca–P product and pru-
ritus.9,14
  The strong points in our study are including
iPTH measurement and excluding patients
with cutaneous lesions; whereas, the small
sample size is a limitation in our study.
In conclusion, our study revealed a signi-
ficant association between serum Ca levels and
cutaneous pruritus. No significant correlation
was found between serum iPTH level and
pruritis. Thus, in patients with ESRD, it is im-
portant to maintain the serum Ca levels at as
close to normal as possible to reduce the pre-
valence of pruritus.
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